owensilcox, Author at European Medical Journal - Page 10 of 26

Neoadjuvant Therapy in TNBC: Current Landscape and Emerging Therapies

Triple-negative breast cancer (TNBC) comprises 10–15% of all breast cancers. It is a very heterogeneous disease, characterized by the…

The latest edition of AMJ Oncology

Uncover everything you need to know from this year’s ASCO congress and beyond in our new Oncology journal, featuring the latest highlights…

Current Approaches to Recurrent and Metastatic Cervical Cancer

Despite improved screening and treatment in developing nations, cervical cancer continues to have a global incidence of approximately…

High-Grade Gallbladder Neuroendocrine Tumor in a Young Female

Neuroendocrine tumors (NET) constitute a heterogeneous group of neoplasms that originate from cells of the diffuse neuroendocrine system…

Prolonged Survival in Fibrolamellar HCC Treatment

Liver cancer is a leading global health concern, ranking as the sixth most common cancer and the third deadliest in 2022, with over…

ASCO 2025 Interview: Melissa Hudson

I began working at the St. Jude Children’s Research Hospital’s After Completion of Therapy Clinic (Memphis, Tennessee, USA) in the early…

Deucravacitinib Therapy in Plaque Psoriasis

Psoriasis is a common, chronic, inflammatory skin disease characterized by accelerated epidermal proliferation. The most common subtype is…

EULAR 2025 Interview: Daniel Aletaha

RheumaFacts has been one of our major initiatives for some time. The idea is to gather information from all our member countries about…

Revolutionising Respiratory Allergy: Mário Morais-Almeida

Since 1994, the field of allergy and clinical immunology has undergone a profound transformation, both in terms of scientific understanding…

EMJ's latest Interventional Cardiology Publication

Covering everything you need to know from EuroPCR 2025 and beyond, our new journal explores the evolving role of drug-coated balloons in…